Reporter brief
Topical rapamycin tested in RCT to assess effects on skin epigenetic aging markers
What happened
This was a randomized controlled trial investigating whether topical rapamycin ointment applied to forearms could induce epigenetic changes in skin tissue. The study specifically tested whether the drug could reverse inflammation and reset epigenetic aging markers locally in the skin.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Limitations have not been recorded; consult the primary source.
Study design and sample
Rct; Human.
Not recorded.
- Design
- Rct
- Sample
- —
- Journal
- The University of Texas Health Science Center at San Antonio
- Published
- Jul 19, 2023
Effect size
Not recorded.
Caveats
- Assessment: Superseded.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Rapamycin timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.